
Savitha M. Rao
Examiner (ID: 10492, Phone: (571)270-5315 , Office: P/1621 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629, 1614, 1621, 1691, 4131 |
| Total Applications | 1525 |
| Issued Applications | 872 |
| Pending Applications | 108 |
| Abandoned Applications | 583 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12880597
[patent_doc_number] => 20180185374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => INHIBITORS OF MTOR KINASE AS ANTI-VIRAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 15/669483
[patent_app_country] => US
[patent_app_date] => 2017-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38878
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15669483
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/669483 | INHIBITORS OF MTOR KINASE AS ANTI-VIRAL AGENTS | Aug 3, 2017 | Abandoned |
Array
(
[id] => 15975553
[patent_doc_number] => 10668078
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-02
[patent_title] => Methods and compositions for treating mesothelioma and small lung cancer that express midkine
[patent_app_type] => utility
[patent_app_number] => 16/312478
[patent_app_country] => US
[patent_app_date] => 2017-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 19
[patent_no_of_words] => 6246
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16312478
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/312478 | Methods and compositions for treating mesothelioma and small lung cancer that express midkine | Jul 27, 2017 | Issued |
Array
(
[id] => 12831502
[patent_doc_number] => 20180169006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => CO-PACKAGED DRUG PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 15/660422
[patent_app_country] => US
[patent_app_date] => 2017-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30260
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15660422
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/660422 | CO-PACKAGED DRUG PRODUCTS | Jul 25, 2017 | Abandoned |
Array
(
[id] => 12702439
[patent_doc_number] => 20180125979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGS
[patent_app_type] => utility
[patent_app_number] => 15/660932
[patent_app_country] => US
[patent_app_date] => 2017-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15660932
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/660932 | PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGS | Jul 25, 2017 | Abandoned |
Array
(
[id] => 12029435
[patent_doc_number] => 20170319533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'COMPOSITIONS AND METHODS OF USE OF PHORBOL ESTERS'
[patent_app_type] => utility
[patent_app_number] => 15/658730
[patent_app_country] => US
[patent_app_date] => 2017-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42971
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15658730
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/658730 | Compositions and methods of use of phorbol esters | Jul 24, 2017 | Issued |
Array
(
[id] => 14774769
[patent_doc_number] => 20190262282
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => A WOUND HEALING COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/314380
[patent_app_country] => US
[patent_app_date] => 2017-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13485
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16314380
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/314380 | Wound healing composition | Jul 2, 2017 | Issued |
Array
(
[id] => 13699659
[patent_doc_number] => 20170360784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => TRIZOL-1-OL ANALOGS ANTI-RETROVIRAL LATENCY DRUGS
[patent_app_type] => utility
[patent_app_number] => 15/639575
[patent_app_country] => US
[patent_app_date] => 2017-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13484
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15639575
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/639575 | TRIZOL-1-OL ANALOGS ANTI-RETROVIRAL LATENCY DRUGS | Jun 29, 2017 | Abandoned |
Array
(
[id] => 12637266
[patent_doc_number] => 20180104252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => AEROSOL FLUOROQUINOLONE FORMULATIONS FOR IMPROVED PHARMACOKINETICS
[patent_app_type] => utility
[patent_app_number] => 15/635818
[patent_app_country] => US
[patent_app_date] => 2017-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17023
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15635818
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/635818 | Aerosol fluoroquinolone formulations for improved pharmacokinetics | Jun 27, 2017 | Issued |
Array
(
[id] => 14306151
[patent_doc_number] => 20190142779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => COMPOSITIONS COMPRISING RUMENIC ACID-RICH CONJUGATED LINOLEIC ACID FOR BRAIN HEALTH
[patent_app_type] => utility
[patent_app_number] => 16/312483
[patent_app_country] => US
[patent_app_date] => 2017-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16312483
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/312483 | Compositions comprising rumenic acid-rich conjugated linoleic acid for brain health | Jun 19, 2017 | Issued |
Array
(
[id] => 14649197
[patent_doc_number] => 20190231727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => COMPOSITIONS COMPRISING RUMENIC ACID-RICH CONJUGATED LINOLEIC ACID FOR JOINT HEALTH
[patent_app_type] => utility
[patent_app_number] => 16/315011
[patent_app_country] => US
[patent_app_date] => 2017-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7302
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315011
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315011 | Compositions comprising rumenic acid-rich conjugated linoleic acid for joint health | Jun 19, 2017 | Issued |
Array
(
[id] => 15020613
[patent_doc_number] => 20190321311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => Cancer Treatment by Simultaneous Targeting Energy Metabolism and Intracellular pH
[patent_app_type] => utility
[patent_app_number] => 16/310379
[patent_app_country] => US
[patent_app_date] => 2017-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13948
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16310379
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/310379 | Cancer Treatment by Simultaneous Targeting Energy Metabolism and Intracellular pH | Jun 13, 2017 | Abandoned |
Array
(
[id] => 12404973
[patent_doc_number] => 09968586
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-15
[patent_title] => Mast cell stabilizers treatment for systemic disorders
[patent_app_type] => utility
[patent_app_number] => 15/621857
[patent_app_country] => US
[patent_app_date] => 2017-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31821
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15621857
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/621857 | Mast cell stabilizers treatment for systemic disorders | Jun 12, 2017 | Issued |
Array
(
[id] => 17028449
[patent_doc_number] => 11090247
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-17
[patent_title] => Compositions for protecting the skin from heavy metals and formaldehyde
[patent_app_type] => utility
[patent_app_number] => 16/464209
[patent_app_country] => US
[patent_app_date] => 2017-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7798
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16464209
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/464209 | Compositions for protecting the skin from heavy metals and formaldehyde | Jun 1, 2017 | Issued |
Array
(
[id] => 16742008
[patent_doc_number] => 10966977
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-06
[patent_title] => Combination of anti-CD20 antibody, P13 kinase-delta selective inhibitor, and BTK inhibitor to treat b-cell proliferative disorders
[patent_app_type] => utility
[patent_app_number] => 16/304590
[patent_app_country] => US
[patent_app_date] => 2017-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 25195
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16304590
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/304590 | Combination of anti-CD20 antibody, P13 kinase-delta selective inhibitor, and BTK inhibitor to treat b-cell proliferative disorders | May 25, 2017 | Issued |
Array
(
[id] => 11954637
[patent_doc_number] => 20170258788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'CARBOSTYRIL DERIVATIVES AND SEROTONIN REUPTAKE INHIBITORS FOR TREATMENT OF MOOD DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 15/604720
[patent_app_country] => US
[patent_app_date] => 2017-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13284
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15604720
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/604720 | CARBOSTYRIL DERIVATIVES AND SEROTONIN REUPTAKE INHIBITORS FOR TREATMENT OF MOOD DISORDERS | May 24, 2017 | Abandoned |
Array
(
[id] => 14621653
[patent_doc_number] => 20190224194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => COMPOSITION FOR TREATING OCULAR DISEASES AND METHODS OF USAGE AND MAKING
[patent_app_type] => utility
[patent_app_number] => 16/336204
[patent_app_country] => US
[patent_app_date] => 2017-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13027
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -79
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16336204
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/336204 | Composition for treating ocular diseases and methods of usage and making | May 18, 2017 | Issued |
Array
(
[id] => 14227057
[patent_doc_number] => 20190125701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => Compositions and Methods for Treating Viral Infection in Mammals
[patent_app_type] => utility
[patent_app_number] => 16/098535
[patent_app_country] => US
[patent_app_date] => 2017-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22994
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098535
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/098535 | Compositions and Methods for Treating Viral Infection in Mammals | May 3, 2017 | Abandoned |
Array
(
[id] => 14563875
[patent_doc_number] => 20190209544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => Antimicrobial Compositions for Topical Use
[patent_app_type] => utility
[patent_app_number] => 16/303299
[patent_app_country] => US
[patent_app_date] => 2017-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3569
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16303299
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/303299 | Antimicrobial compositions for topical use | May 3, 2017 | Issued |
Array
(
[id] => 11864743
[patent_doc_number] => 20170232028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING THREE ANTIBIOTICS'
[patent_app_type] => utility
[patent_app_number] => 15/585879
[patent_app_country] => US
[patent_app_date] => 2017-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9807
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15585879
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/585879 | Pharmaceutical compositions comprising three antibiotics | May 2, 2017 | Issued |
Array
(
[id] => 12445236
[patent_doc_number] => 09980925
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-29
[patent_title] => Xanthohumol in antiarrythmic applications
[patent_app_type] => utility
[patent_app_number] => 15/496022
[patent_app_country] => US
[patent_app_date] => 2017-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 16
[patent_no_of_words] => 6450
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15496022
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/496022 | Xanthohumol in antiarrythmic applications | Apr 24, 2017 | Issued |